SightfileU.S. market data from official filings

Companies › INO

Inovio Pharmaceuticals Inc (INO)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001055726 · EDGAR filings · Updated 2026-07-10

Inovio Pharmaceuticals Inc (INO) has reported institutional ownership of 45.4%, with 100 institutional managers holding positions valued at $54.6M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
45.4%
Institutional managers
100
Reported 13F value
$54.6M
Insider activity
34 trans.
$0 net flat
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Inovio Pharmaceuticals Inc has 100 institutional holders and institutional ownership of 45.4%.

Insider activity

Insiders reported 34 transactions (0 buys, 0 sells) across 11 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-13 (recurring since 2024-11-14) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2023-11-02 (recurring since 2023-11-02) — source filing. The authoritative details are those stated in the filing itself.

Related companies

LAKELAND INDUSTRIES INC (LAKE) · OUTSET MED INC (OM) · MDXHEALTH SA (MDXH) · BIODESIX INC (BDSX) · MESOBLAST LTD (MESO) · SPRUCE BIOSCIENCES INC COM NEW (SPRB)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.